CausalSentinel

Protein Dossier — ISLR2 (Immunoglobulin superfamily containing leucine-rich repeat protein 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
LDL cholesterol -0.184 0.0282 7.03e-11 Wald ratio 1 trans 0.988
Total cholesterol -0.115 0.027 2.27e-05 Wald ratio 1 trans NA
Triglycerides -0.0999 0.0259 1.16e-04 Wald ratio 1 trans NA
Diagnoses - main ICD10: L03 Cellulitis 0.00251 0.000842 0.00289 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: L03 Cellulitis 0.00251 0.000842 0.00289 Inverse variance weighted 2 trans NA
Depressive symptoms -0.0473 0.0168 0.00488 Inverse variance weighted 2 cis NA
Depressive symptoms -0.0473 0.0168 0.00488 Inverse variance weighted 2 trans NA
Chronic kidney disease 0.158 0.059 0.0073 Inverse variance weighted 2 cis NA
Chronic kidney disease 0.158 0.059 0.0073 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: H25 Senile cataract 0.002 0.000824 0.0149 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: H25 Senile cataract 0.002 0.000824 0.0149 Inverse variance weighted 2 trans NA
HDL cholesterol 0.0642 0.0267 0.016 Wald ratio 1 trans NA
…and 153 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

1 association rows across 1 traits (1 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Standing height (UKB data field 50) 3e-12 rs112473448 1 GCST90468178 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 110 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
undetermined early-onset epileptic encephalopathy 0.438 established (curated) no MR -> candidate analysis
developmental and epileptic encephalopathy, 33 0.438 established (curated) no MR -> candidate analysis
aortic disorder 0.419 common-variant locus no MR -> candidate analysis
Dermatochalasis 0.318 common-variant locus no MR -> candidate analysis
skin aging 0.245 common-variant locus no MR -> candidate analysis
COVID-19 0.206 common-variant locus no MR -> candidate analysis
Abnormality of the skeletal system 0.164 common-variant locus no MR -> candidate analysis
osteoarthritis 0.102 common-variant locus no MR -> candidate analysis

Of the 8 rows above, 8 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.0005, LOEUF=0.954 — LoF-tolerant
GWAS Catalog 55 unique SNPs / 110 rows
ClinVar 133 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance